Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted Feldman

Showing results (161-170 of 221) with videos related to

Pageof 23
Sort By:
Heart (British Cardiac Society)|August 6, 2018
Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patientsSaibal Kar, Ted Feldman, Atif Qasim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX studyChristos V Bourantas, Yao-Jun Zhang, Scot Garg, et al.
The Journal of Heart Valve Disease|September 13, 2018
Survival Advantage of MitraClip® Over Medical Treatment in Patients with Mitral Regurgitation: A Meta-AnalysisTomás Benito-González, Rodrigo Estévez-Loureiro, Ignacio Iglesias-Gárriz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 3, 2020
Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve RegistryDale J Murdoch, Janarthanan Sathananthan, Mark Hensey, et al.
Circulation|December 28, 2018
One-Year Outcomes After MitraClip for Functional Mitral RegurgitationGorav Ailawadi, D Scott Lim, Michael J Mack, et al.
Circulation|February 26, 2014
Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score"Vasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 31, 2017
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patientsIan T Meredith, Nicolas Dumonteil, Daniel J Blackman, et al.
The American Journal of Cardiology|June 19, 2024
TRISCEND II: Novel Randomized Trial Design for Transcatheter Tricuspid Valve ReplacementPaul A Grayburn, Susheel K Kodali, Rebecca T Hahn, et al.
Pageof 23

Showing results (161-170 of 221) with videos related to

Sort By:
Pageof 23
Heart (British Cardiac Society)|August 6, 2018
Five-year outcomes of transcatheter reduction of significant mitral regurgitation in high-surgical-risk patientsSaibal Kar, Ted Feldman, Atif Qasim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 15, 2014
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX studyChristos V Bourantas, Yao-Jun Zhang, Scot Garg, et al.
The Journal of Heart Valve Disease|September 13, 2018
Survival Advantage of MitraClip® Over Medical Treatment in Patients with Mitral Regurgitation: A Meta-AnalysisTomás Benito-González, Rodrigo Estévez-Loureiro, Ignacio Iglesias-Gárriz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 3, 2020
Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve RegistryDale J Murdoch, Janarthanan Sathananthan, Mark Hensey, et al.
Circulation|December 28, 2018
One-Year Outcomes After MitraClip for Functional Mitral RegurgitationGorav Ailawadi, D Scott Lim, Michael J Mack, et al.
Circulation|February 26, 2014
Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score"Vasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.
Circulation|April 8, 2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upJavaid Iqbal, Yao-Jun Zhang, David R Holmes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 31, 2017
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patientsIan T Meredith, Nicolas Dumonteil, Daniel J Blackman, et al.
The American Journal of Cardiology|June 19, 2024
TRISCEND II: Novel Randomized Trial Design for Transcatheter Tricuspid Valve ReplacementPaul A Grayburn, Susheel K Kodali, Rebecca T Hahn, et al.
Pageof 23